T1	Participants 79 141	patients resuscitated from near-fatal ventricular arrhythmias.
T2	Participants 607 757	patients who had been resuscitated from near-fatal ventricular fibrillation or who had undergone cardioversion from sustained ventricular tachycardia.
T3	Participants 758 919	Patients with ventricular tachycardia also had either syncope or other serious cardiac symptoms, along with a left ventricular ejection fraction of 0.40 or less.
T4	Participants 1268 1500	Of 1016 patients (45 percent of whom had ventricular fibrillation, and 55 percent ventricular tachycardia), 507 were randomly assigned to treatment with implantable cardioverter-defibrillators and 509 to antiarrhythmic-drug therapy.
T5	Participants 2094 2192	survivors of ventricular fibrillation or sustained ventricular tachycardia causing severe symptoms
